Science Explorer Back to mapMap
Discussion
Researcher · National Institute of Pharmaceutical Education and Research · India

Pawan Devangan

Pawan Devangan publishes mostly in Pharmaceutical Science, Materials Chemistry and Rheumatology, on topics such as Drug Solubulity and Delivery Systems, Osteoarthritis Treatment and Mechanisms and Crystallization and Solubility Studies.

ORCID 0000-0002-2858-3653 OpenAlex
World rank
#4,481,447
of 7,710,434 ranked researchers
Rank in India
#114,580
of 280,097
Works
21
Citations
74
Citations per work
3.5
h-index
5
i10-index 1Top 93% in Pharmaceutical Science
Pawan Devangan

What does Pawan Devangan research?

Pawan Devangan's work is mostly in Materials Science (15%), Medicine (15%), Pharmacology, Toxicology and Pharmaceutics (11%).

Everything else: 11 works · 51.1% of their workLife Sciences: 4 works · 18.8% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 11.3% of their workPharmaceutical Science: 2 works · 11.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 7.5% of their workMolecular Biology: 2 works · 7.5% of their workPhysical Sciences: 3 works · 15.1% of their workMaterials Science: 3 works · 15.1% of their workMaterials Chemistry: 2 works · 11.3% of their workBiomaterials: 1 works · 3.8% of their workHealth Sciences: 3 works · 15.0% of their workMedicine: 3 works · 15.0% of their workComplementary and alternative medicine: 2 works · 7.5% of their workRheumatology: 2 works · 7.5% of their workTHEIR WORKPawan Devangan21works
Life Sciences19%Physical Sciences15%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1151.1%
    1. Pharmacology, Toxicology and Pharmaceutics211.3%
    2. Biochemistry, Genetics and Molecular Biology27.5%
    1. Materials Science315.1%
    1. Medicine315.0%
  1. 1Pharmaceutical Science11% of their works
  2. 2Materials Chemistry11% of their works
  3. 3Rheumatology8% of their works
  4. 4Complementary and alternative medicine8% of their works
  5. 5Molecular Biology8% of their works
  6. 6Biomaterials4% of their works

Research topics

Which keywords describe Pawan Devangan's research?

The keywords of their largest research topics: Inflammation, Cyclodextrins, Solid Dispersions, Cartilage, Osteoarthritis, Crystallization, Nucleation and Andrographis Paniculata.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Inflammation62 topics
  2. Cyclodextrins51 topic
  3. Solid Dispersions51 topic
  4. Cartilage41 topic
  5. Osteoarthritis41 topic
  6. Crystallization31 topic
  7. Nucleation31 topic
  8. Andrographis Paniculata21 topic
  9. Andrographolide21 topic
  10. Chiral Separation21 topic
  11. Drug Delivery21 topic
  12. Green Analytical Chemistry21 topic
  13. Hyaluronan21 topic
  14. Liquid Chromatography21 topic
  15. Nanocarriers21 topic
  16. Pharmaceutical Analysis21 topic
  17. Proteoglycans21 topic

Where does Pawan Devangan work?

Pawan Devangan's main affiliation in the publication record is National Institute of Pharmaceutical Education and Research, India.

How many publications and citations does Pawan Devangan have?

OpenAlex counts 21 works and 74 citations for Pawan Devangan, an h-index of 5, ranking #4,481,447 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pawan Devangan. Posts are plain text and can be reported.